Ribociclib approved as the first-line agent for metastatic breast cancer
Breast cancer is the second leading cause of cancer-related mortality in women, after lung cancer.1 The American Cancer Society...
Lynparza as maintenance therapy for BRCA-mutated ovarian cancer patients
Ovarian cancer is the 7th most commonly diagnosed cancer in women worldwide1 and the 5th most common cause of...
Could vitamin A deficiency result in diabetes?
Diabetes has become a pandemic, with hundreds of new cases being diagnosed daily. Diabetes is caused by the lack...
Being Overweight can be beneficial for Stroke Survivors
Stroke is one of the top 5 leading causes of death in the US alone. Moreover, it dominates the...
US FDA Approves Midostaurin for Treatment of Acute Myeloid Leukemia
The US FDA approved the use of Rydapt (midostaurin) in combination with chemotherapy for treating recently diagnosed adults with...
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) by the FDA
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is not breast cancer but a rare type of T-cell lymphoma that...
FDA Issues Warning Regarding the Use of Balloon Angioplasty For Treatment Of Autonomic Dysfunction Disorders
US Food and Drug Administration (FDA) has warned both patients and doctors alike about the use of balloon angioplasty...
Merkel Cell Carcinoma (MCC) gets it first line of treatment approved by the FDA
Skin cancer is common; however, Merkel cell carcinoma (MCC) is a rare type of aggressive skin cancer that affects...
FDA gives a green signal for maintenance treatment of recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer with Niraparib
Adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer who have responded completely or partially to...
FDA Approves First New Treatment For Frequent Urination In Night
Noctiva a nasal spray for adults with nocturnal polyuria has been approved by the US Food and Drug Administration....